Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-02-17

Clinical Trial Update: Safety Study of Deoxycholic Acid for the Reduction of Localized Subcutaneous Fat in the Submental Area in Subjects 65 to 75 Years of Age [Phase 3]

View source ↗

Summary

Phase 3 safety study completed for deoxycholic acid in reducing localized subcutaneous fat under the chin; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Deoxycholic acid (Deoxycholic acid)

Snippet

Sponsor: Kythera Biopharmaceuticals | Conditions: Moderate to Severe Convexity of Submental Fat, Safety | Phase 3 | Status: COMPLETED | Results posted: 2020-02-17